#LongTermIncentive

Ono Pharmaceutical Co., Ltd. resolved at the Board meeting on March 5, 2026, to introduce a long-term incentive stock compensation plan equivalent to JPY 20,454 million and 8,398,300 shares for employees of its U.S. subsidiary, Deciphera Pharmaceuticals, Inc.

A medium-to-long term incentive compensation plan will be introduced for seven eligible directors, with an annual limit of 30,000 shares and 200 million yen. Proposal to be submitted at the March 27, 2026 shareholders meeting.